Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00070083
Status:
COMPLETED
Last Update Posted:
2009-04-07
First Post:
2003-10-03
Brief Title:
Oblimersen Rituximab Cyclophosphamide Doxorubicin Vincristine and Prednisone in Treating Patients With Stage II Stage III or Stage IV Diffuse Large B-Cell Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI